Marimed (MRMD) investor relations material

Opening remarks and agenda

• The meeting was called to order by the President and CEO, who welcomed attendees and outlined the virtual format and agenda, emphasizing inclusivity and the order of business followed by a Q&A session.

• Legal counsel, independent auditor, and board members were introduced, and meeting roles were assigned.

Board and executive committee updates

• Directors present included the Chairman of the Board and three other board members.

• The re-election of four directors to serve until the 2027 annual meeting was proposed and recommended by the board.

Overview of voting outcomes

• A quorum was confirmed with over 50% of eligible votes present.

• All director nominees were re-elected, and the appointment of the independent auditor for 2026 was approved.

• Final voting results will be filed with the SEC within four business days.